Castle Biosciences, Inc.

CSTL·NasdaqGM·Healthcare
Compare
35.75+0.61 (+1.74%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
After hours35.750.00 (0.00%)Nov 4, 4:26 PM EST

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close35.14
Open36.03
Day range35.0736.43
52-week range17.7244.28
Off day high−1.87%
Off 52-week high−19.26%
Volume462.48K
Avg. volume (3M)368.76K
Market cap1.09B
EPS (TTM)-0.6400
Forward P/E-38.24
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.95
Shares outstanding30.55M
Short interest6.76% of float
Earnings dateNov 5, 2026
Analyst target46.70
Profit margin−5.43%

Against its peers

Compare in full ›
CSTL PSNL NEO BDSX BLLN MYGN
Market cap 1.09B 1.69B 2.22B 226.74M 5.37B 575.81M
P/E (TTM) — — — — 180.8 —
Forward P/E -38.2 -16.3 54.5 -97.7 76.7 -10.2
Price/book 2.3 6.2 2.8 24.8 9.9 1.9
Dividend yield — — — — — —
1-year change +4.68% +105.61% +61.36% +144.77% +1.39% −8.21%
Today +1.74% +0.25% +1.90% +2.09% +3.11% −0.33%

The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.

Latest news

All CSTL news ›
Stock Titan·

Castle Biosciences CEO sells 14,496 shares

Castle Biosciences (CSTL) is a Nasdaq-listed diagnostics company focused on molecular tests for dermatologic and gastroenterological diseases and skin cancers. - [Form 4] CASTLE BIOSCIENCES INC Insider Trading Activity Castle Biosciences…

Stock Titan·

Castle Biosciences Juvenal sells 3,288 shares

INVE Technologies Announces the Commencement of a $20 Million Modified Dutch Auction Tender Offer for its Common Stock Nexera Technologies: Fort Technology’s Subsidiary Logia USA Signs Exclusive Distribution Agreement to Expand Fuel…

Stock Titan·

Castle Biosciences officer proposes $431K share sale

Castle Biosciences (CSTL) is a Nasdaq-listed diagnostics company focused on molecular tests for dermatologic and gastroenterological diseases and skin cancers. Castle Biosciences officer proposes $431K share sale Goldman Sachs & Co. LLC is…

From the 4Search news index, newest first.

In the news

12mentions in 30 days
11with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance